+1-888-308-5802     
Industry Categories News Contact Us

Eli Lilly to spin off its Greenfield-based animal health arm, Elanco

Author : Ojaswita Kutepatil | Published Date : 2018-07-27 

Eli Lilly & Co., a leading pharmaceutical company has reportedly announced its plan to spin off its Greenfield-based animal health unit - Elanco, after going through a month-long review regarding its business in animal healthcare and agriculture. The company is expecting to complete the spinoff by the second half of this year, while the initial offering is anticipated to go public over the coming weeks.

Reportedly, the spinoff is considered to be one of the biggest strategic decisions taken by Dave Ricks, the Chief Executive Officer of Eli Lilly. The CEO revealed in a company statement that the decision for the spinoff had been taken mainly in favor of their shareholders.

For the record, Elanco sells medication for pets and livestock and had USD 3.09 billion in revenue last year. The company has scaled rapidly through its acquisition strategies, and have taken almost 10 companies since 2007 which includes the buyout of Novartis AG’s animal-health unit for USD 5.4 billion in 2015. A year after, the unit opened a 48,000-sq foot research facility next to its Greenfield Indiana, H.Q. to develop vaccines for livestock and pets.

According to the Eli Lilly, its per share earning has risen from $1.30 average in the second quarter to $1.50. The company has also raised its full-year adjusted earnings forecast from a $5.10 to $5.20 in June to $5.40 to $5.50 a share.

As per an official statement, the pharma company plans to offer less than 20% of Elanco stock in an initial public offering. The firm later plans to sell the remaining shares through a tax-efficient transaction.

Further, Lilly stated that the company doesn’t plan to increase the price of any drug for the whole year and will remain focused on gaining profit through volume and not through higher drug prices.

About Author

Ojaswita Kutepatil

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, worked as a BDE and Technical Engineer before switching her profession to content writing. Currently, she works at AlgosOnline. as an Content writer, where she pens down write-ups pertaining to the market research industry. Crafting, reading, and music are some of her other areas of interest.

She can be contacted at- [email protected] | https://twitter.com/ojaswita_k

Related News

Siemens Gamesa unveils its first-ever 10MW offshore wind turbine

Published Date: 2019-01-18         Author: Ojaswita Kutepatil

The new wind turbine’s nacelles are expected to be initially manufactured at SGRE’s factory in Germany’s Cuxhaven. Siemens Gamesa Renewable Energy (SGRE), a renewable energy industry leader headquartered in Spain, has reportedly unveiled its latest SG 10.0-193 DD, the company&rs... Read More

Rubrik Inc., raises $261 million in the latest Series E funding round

Published Date: 2019-01-16         Author: Ojaswita Kutepatil

Rubrik has raised up to USD 553 million in funds so far, including the Series E round. Rubrik Inc., a data management company based in California, USA, has reportedly secured as much as US$ 261 million in Series E funding, the latest financing round of the company led by Bain Capital Ventures, a ... Read More

American Express buys Japanese restaurant booking app Pocket Concierge

Published Date: 2019-01-16         Author: Ojaswita Kutepatil

The service was reportedly launched in 2013 to help customers book quality restaurants that have months-long waiting lists for reservations.   The company currently works with more than 800 restaurants and has made available its app in English, Japanese and Chinese. U.S. card issuer... Read More

© 2019 Fractovia. All Rights Reserved